In particular, chr.3p, whose loss is a typical genomic aberration in ccRCC, contains several chromatin modifiers, such as PBRM1, SETD2, and BAP1, and these genetic mutations are also frequently observed in the contralateral allele15,16. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.